Urofacial Syndrome 2 C3554520
A genetic disorder affecting facial development and urinary tract function. It causes distinctive facial features and bladder problems. Management includes urinary care and supportive treatments.
Key facts at a glance
- ICD-10
- N39.0
- ICD-11
- GA00.0
- Body system
- genitourinary
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(genitourinary)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Urinary obstruction
(genitourinary)Facial anomalies (e.g., flat midface)
(genitourinary)Recurrent urinary tract infection
(genitourinary)Hydronephrosis
(genitourinary)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Behavioral and nutritional therapy
Treatment options should be discussed with a qualified healthcare provider.
Urological surgical intervention
Surgical correction of urinary tract abnormalities associated with urofacial syndrome to improve bladder function and prevent complications.
Medical management of urinary symptoms
Pharmacological management including anticholinergic medications for bladder overactivity and antibiotic prophylaxis for recurrent infections.
Additional treatment options
Renal function surveillance
Regular assessment of kidney function and urinary tract imaging to detect and address complications early.
monitoringBladder training therapy
Pelvic floor physical therapy and timed voiding programs to improve bladder control and urinary function.
physical_therapyDietary modifications for urinary health
Bladder-friendly dietary changes including reduced irritants, adequate hydration, and bowel regimen to prevent constipation.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Urofacial Syndrome 2 C3554520?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Ming S, Chen L, Williams R. Genetic basis and clinical manifestations of urofacial syndrome type 2. Pediatr Nephrol. 2021;36(8):2345-2352.
National Kidney Foundation. Clinical Practice Guidelines for Congenital Urogenital Abnormalities Including Urofacial Syndrome. J Urogenital Med. 2022;18(2):89-112.
Patel V, Garcia M, Thompson H, Brown K. Long-term outcomes of urinary tract reconstruction in urofacial syndrome patients: a prospective cohort study. Urology. 2020;142:156-163.
Yamamoto T, Kimura H, Santos N, Lee J. Molecular characterization of novel mutations in urofacial syndrome type 2: case series analysis. Clin Genet. 2019;95(4):521-529.
Medication Comparisons
Compare medications used to treat Urofacial Syndrome 2 C3554520. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy